May 6, 2026
Abstract
This post explains that antibiotic resistance occurs when genetic mutations allow a small fraction of bacteria to survive treatment, reproduce, and eventually dominate the population. While it acknowledges that mutation-driven survival is real, it argues this process does not support selection in a meaningful evolutionary sense. Instead, antibiotics (or the immune system) are described as targeting the most common bacterial genetic patterns, killing the vast majority while leaving only vastly rare variants to persist.
The author further claims that these surviving mutants are typically weaker and often eliminated by the immune system, with only rare cases leading to ongoing resistance. They argue that, overall, bacteria tend to become less harmful over time since killing the host is disadvantageous. The conclusion is that antibiotic resistance is simply the gradual elimination of bacteria rather than evidence of natural selection driving meaningful evolutionary improvement.
What is “anti-biotic resistance?”
Anti-biotic resistance occurs when bacteria develop the ability to withstand the effects of antibiotics, making it difficult to impossible to treat bacterial infections. This ability is caused by mutations within the bacteria’s genetics, however, such random mutations are not good examples of Natural Selection. The evidence shows selection, but mostly through loss-of-function or degradative trade-offs rather than clear upward complexity demanded by macroevolutionary predictions.
Bacteria Mutate? YES!
Undeniably bacteria (and viruses are similar when treated with drugs) “survive” by mutation. This is true. Note that we placed survive in quotes because anti-biotics are made to destroy the entire population of the bacteria infecting the patient. The formula used to do this is created based on the current dominant allele frequency. The anti-biotic, whether manmade or as synthesized by our own immune system, like a mafia hitman, is provided a picture of who to eliminate. This picture is a specific genetic sequence, sometimes many millions of sequences in length. They only kill that specific sequence (ideally). That selected sequence in the anti-biotic medication (or by our immune system) attacks the dominant (most common) allele frequency in the population.
Dominant Allele Frequencies in Bacteria are 99.99% identical
Bacteria are very synonymous (similar), usually more than 99.99% genetically identical. And they replicate rapidly. The anti-biotic is injected and it goes in and effectively kills more than 99% of all the bacteria. However, that less than 1% that “survived” the anti-biotic begin to reproduce. This means that the mutants, the oddballs from the original population now begin to dominate. These mutants reproduce but they are usually weaker than the original strain so our immunity kills them off. However, very rarely, they survive and perhaps a new antibiotic is used. As we saw with the changing strain of COVID (a virus and not a bacteria) this happens over and over. -1
MRSA
Observably, outside a handful of examples like botulinum or MRSA, the immune system, with our without anti-biotics, will continue to destroy the bacteria (or virus) until it becomes inert (harmless). In the exceedingly rare cases individuals die it the infection, especially those with preexisting conditions.
Weaker Mutations are Beneficial- not more deadly versions
Death of the host is not beneficial to bacteria because they lose their ability to live. Therefore, from an evolutionary view, the beneficial direction bacteria mutates is toward becoming weaker (as compared to more deadly) and inert. The function of bacteria (and viruses) are amazing but the part that sounds like evolution, the mutation part, is effectively the chronological destruction of the invading bacteria by our own immune system (or manmade drug). Rarely can a deformed bacteria, perhaps one that has been destroyed by many generation become resistant to antibiotics? Yes, of course, no one denies that. However, antibiotic resistance provides no evidence to defend macroevolution.
Summary
Antibiotic resistance occurs when bacteria develop the ability to withstand the effects of antibiotics, making infections harder to treat. This ability comes from mutations in the bacteria’s genetics—some random, some pre-existing. While it is often called an example of natural selection due to beneficial mutations, it’s important to note that these mutations usually come with detrimental fitness costs, meaning resistant bacteria are often weaker or less efficient than the original strain in the absence of antibiotics. This does not bode well for the theory of evolution.
When antibiotics are applied, they kill the majority of bacteria, leaving only a small fraction that carry mutations allowing survival. These survivors, often hobbled and disabled, then reproduce, gradually dominating the population. Therefore, most resistant mutants are still less fit than the original population, and our immune system continues to destroy many of them. Only rarely does a resistant strain persist long-term or require new antibiotics to be managed.
Interestingly, evolution does not favor more deadly bacteria or viruses because they kill their hosts. In many cases, pathogens evolve in ways that balance survival with the ability to reproduce by becoming inert or harmless. In other words, while antibiotic resistance is real, it often comes with trade-offs that reduce overall bacterial fitness as opposed to demonstrating evidence that defends the pillars of evolutionary theory.
- Andersson & Hughes, Nat Rev Microbiol 2014 Sublethal antibiotics accelerate resistance
- Beceiro et al., Clin Microbiol Rev 2013 Resistance and virulence trade-offs
- Pinheiro et al., 2020, Predicting trajectories of resistance
- PMC, 2015, Within-host evolution of pathogens
- Didelot X, Walker AS, Peto TE, Crook DW, Wilson DJ. Within-host evolution of bacterial pathogens. Nat Rev Microbiol. 2016 Mar;14(3):150-62. doi: 10.1038/nrmicro.2015.13. Epub 2016 Jan 19. PMID: 26806595; PMCID: PMC5053366.
